Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Mothers With ADHD and Their Young Children Via Telehealth
NCT04240756Phase 3Completed
- Sponsor
- University of Maryland College Park
- Start
- Aug 2020
- Primary completion
- May 2025
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of dextroamphetamine + amphetamine in attention deficit hyperactivity disorder (ADHD), sponsored by University of Maryland College Park. Started Aug 2020; status: completed.
02
Drugs
dextroamphetamine + amphetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04240756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04240756.